Page last updated: 2024-08-25

rosiglitazone and Bronchial Hyperreactivity

rosiglitazone has been researched along with Bronchial Hyperreactivity in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Casale, T; Dimov, V; Sandhu, AK; Sandhu, MS; Walters, RW; Wichman, T	1
Belvisi, MG; Birrell, MA; Leonard, T; McCluskie, K; Patel, HJ; Wong, S; Yacoub, MH	1
Hart, CM; Holguin, F; Rojas, M	1

Trials

1 trial(s) available for rosiglitazone and Bronchial Hyperreactivity

Article	Year
The use of the peroxisome proliferator-activated receptors γ agonist rosiglitazone to treat airway hyperreactivity. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2012, Volume: 109, Issue:1 Topics: Adult; Animals; Asthma; Breath Tests; Bronchial Hyperreactivity; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Feasibility Studies; Female; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Mice; Middle Aged; Nitric Oxide; PPAR gamma; Rosiglitazone; Thiazolidinediones	2012

Article

Year

The use of the peroxisome proliferator-activated receptors γ agonist rosiglitazone to treat airway hyperreactivity.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2012, Volume: 109, Issue:1

Topics: Adult; Animals; Asthma; Breath Tests; Bronchial Hyperreactivity; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Feasibility Studies; Female; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Mice; Middle Aged; Nitric Oxide; PPAR gamma; Rosiglitazone; Thiazolidinediones

2012

Other Studies

2 other study(ies) available for rosiglitazone and Bronchial Hyperreactivity

Article	Year
PPAR-gamma agonists as therapy for diseases involving airway neutrophilia. The European respiratory journal, 2004, Volume: 24, Issue:1 Topics: Administration, Oral; Airway Resistance; Analysis of Variance; Animals; Bronchial Hyperreactivity; Disease Models, Animal; Inflammation Mediators; Lipopolysaccharides; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neutrophils; Peroxisome Proliferator-Activated Receptors; Probability; Reference Values; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones	2004
The peroxisome proliferator activated receptor gamma (PPARgamma) ligand rosiglitazone modulates bronchoalveolar lavage levels of leptin, adiponectin, and inflammatory cytokines in lean and obese mice. Lung, 2007, Volume: 185, Issue:6 Topics: Adiponectin; Animals; Biomarkers; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Hypoglycemic Agents; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; PPAR gamma; Rosiglitazone; Thiazolidinediones; Treatment Outcome	2007

Article

Year

PPAR-gamma agonists as therapy for diseases involving airway neutrophilia.

The European respiratory journal, 2004, Volume: 24, Issue:1

Topics: Administration, Oral; Airway Resistance; Analysis of Variance; Animals; Bronchial Hyperreactivity; Disease Models, Animal; Inflammation Mediators; Lipopolysaccharides; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neutrophils; Peroxisome Proliferator-Activated Receptors; Probability; Reference Values; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones

2004

The peroxisome proliferator activated receptor gamma (PPARgamma) ligand rosiglitazone modulates bronchoalveolar lavage levels of leptin, adiponectin, and inflammatory cytokines in lean and obese mice.

Lung, 2007, Volume: 185, Issue:6

Topics: Adiponectin; Animals; Biomarkers; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Hypoglycemic Agents; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; PPAR gamma; Rosiglitazone; Thiazolidinediones; Treatment Outcome

2007